Laboratorio Reig Jofre, S.A. (BME:RJF)
Spain · Delayed Price · Currency is EUR 2.730
-0.020 (-0.73%)
Aug 7, 2026, 11:27 AM CET
Laboratorio Reig Jofre Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 332.15 | 331.1 | 338.9 | 316.09 | 271.15 | 236.23 | |
Revenue Growth | -0.42% | -2.30% | 7.22% | 16.57% | 14.78% | 2.67% |
Cost of Revenue | 130.43 | 135.28 | 140.15 | 133.72 | 113.1 | 91.49 |
Gross Profit | 100.11 | 195.81 | 198.75 | 182.37 | 158.06 | 144.75 |
Selling, General & Admin | 100.6 | 94.9 | 87.75 | 75.91 | 70.47 | 64.19 |
Depreciation & Amortization Expenses | 25.35 | 24.79 | 23.36 | 23.15 | 21.06 | 18.05 |
Other Operating Expenses | 63.38 | 71.89 | 75.03 | 72.8 | 57.02 | 53.21 |
Total Operating Expenses | 189.33 | 191.58 | 186.14 | 171.86 | 148.55 | 135.45 |
Operating Income | 6.2 | 4.24 | 12.61 | 10.51 | 9.51 | 8.86 |
Interest Income | 4.7 | -0.31 | -0.12 | 0.98 | 1.69 | 0.09 |
Interest Expense | -1.05 | -1.91 | -1.97 | -1.24 | -1 | -0.91 |
Other Non-Operating Income (Expense) | -1.39 | 1.66 | 0.34 | -0.82 | -2.8 | -5.9 |
Total Non-Operating Income (Expense) | 2.26 | -0.55 | -1.75 | -1.08 | -2.1 | -6.72 |
Pretax Income | 7.57 | 6.32 | 11.82 | 10.5 | 8.76 | 5.79 |
Provision for Income Taxes | 0.66 | 1.32 | 1.36 | 1.1 | 0.66 | 0.71 |
Net Income | 6.91 | 5 | 10.47 | 9.4 | 8.11 | 5.08 |
Minority Interest in Earnings | -0 | -0.02 | 0.09 | -0.01 | -0 | - |
Net Income to Common | 3.48 | 5.02 | 10.38 | 9.41 | 8.11 | 5.09 |
Net Income Growth | -45.98% | -51.64% | 10.37% | 16.04% | 59.21% | -10.23% |
Shares Outstanding (Basic) | 81 | 81 | 80 | 80 | 79 | 78 |
Shares Outstanding (Diluted) | 81 | 81 | 80 | 80 | 79 | 78 |
Shares Change | 0.01% | 1.66% | -0.01% | 1.50% | 1.32% | 1.13% |
EPS (Basic) | 0.04 | 0.06 | 0.13 | 0.12 | 0.10 | 0.07 |
EPS (Diluted) | 0.04 | 0.06 | 0.13 | 0.12 | 0.10 | 0.07 |
EPS Growth | -45.99% | -53.85% | 8.33% | 20.00% | 42.86% | 0% |
Free Cash Flow | - | -13.78 | 11.08 | 6.65 | 4.75 | -0 |
Free Cash Flow Growth | - | - | 66.51% | 40.10% | - | - |
Free Cash Flow Per Share | - | -0.17 | 0.14 | 0.08 | 0.06 | -0.00 |
Dividends Per Share | - | - | 0.049 | 0.040 | 0.040 | 0.040 |
Dividend Growth | - | - | 22.50% | 0% | 0% | -11.11% |
Gross Margin | 30.14% | 59.14% | 58.65% | 57.70% | 58.29% | 61.27% |
Operating Margin | 1.87% | 1.28% | 3.72% | 3.33% | 3.51% | 3.75% |
Profit Margin | 2.08% | 1.51% | 3.09% | 2.97% | 2.99% | 2.15% |
FCF Margin | - | -4.16% | 3.27% | 2.10% | 1.75% | -0.00% |
EBITDA | 6.2 | 29.02 | 35.97 | 33.66 | 30.57 | 8.88 |
EBITDA Margin | 1.87% | 8.77% | 10.61% | 10.65% | 11.27% | 3.76% |
EBIT | 6.2 | 4.24 | 12.61 | 10.51 | 9.51 | 8.86 |
EBIT Margin | 1.87% | 1.28% | 3.72% | 3.33% | 3.51% | 3.75% |
Effective Tax Rate | 8.74% | 20.92% | 11.46% | 10.47% | 7.51% | 12.31% |